Naunyn Schmiedebergs Arch Pharmacol
Naunyn-Schmiedeberg's Archives of Pharmacology
0028-1298
1432-1912
Springer-Verlag
Berlin/Heidelberg


1915621
17295025
137
10.1007/s00210-007-0137-y
Original Article


Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries

Gupta
Saurabh

1

Lozano-Cuenca
Jair

2

Villalón
Carlos M.

2

de Vries
René

1

Garrelds
Ingrid M.

1

Avezaat
Cees J. J.

3

van Kats
Jorge P.

4

Saxena
Pramod R.

1

MaassenVanDenBrink
Antoinette

+31-10-4087537/47
+31-10-4089458
a.vanharen-maassenvandenbrink@erasmusmc.nl

1

1
Department of Pharmacology, Erasmus MC, University Medical Center Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands 
2
Departamento de Farmacobiología, Cinvestav-Coapa, Czda. de los Tenorios 235, Col. Granjas-Coapa, Deleg. Tlalpan, C.P. 14330 Mexico D.F., Mexico 
3
Department of Neurosurgery, Erasmus MC, University Medical Center Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands 
4
Thoracic Surgery and Heart Valve Bank, Erasmus MC, University Medical Center Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands 

13
2
2007

3
2007

375
1
29
38
12
9
2006

15
1
2007


© Springer-Verlag 2007

1
N
ω
l
l
+
1
+
 channels or cAMP-mediated mechanisms. Therefore, these relaxant responses to capsaicin are likely to be attributed to a non-specific, CGRP-independent mechanism.

Keywords
Capsaicin
CGRP
Human coronary artery
Human meningeal artery
Porcine coronary artery

issue-copyright-statement
© Springer-Verlag 2007




Introduction
1997
2002
2006
2+
1988
1995
2006
2005
2004b
2006
2002
2000
2004
2003
2004a
2006a
1997
1999
2002
2006b
2002
2006c
1988
1987
1997
1996
1997
). Therefore, it is of interest to investigate the release of endogenous CGRP in various blood vessels and capsaicin seems most appropriate for such studies.
1991a
1987
1991b
2006
2001
1997
2+
+
 channels. Therefore, in the present study, we tried to characterise capsaicin-induced relaxant response in human and porcine vessels, with special emphasis on the role of CGRP, and also investigated other mechanisms, using different pharmacological tools.

Materials and methods
Tissue preparation
n
n
2
4
2
4
3
2
4
2
4
3
 25 and glucose 11.1; pH 7.4.

Functional studies
l
100
1987
2α
+
2006b
c
8–37
2006b
c
1
1996
1989
N
ω
l
l
2004a
b
2006
2006
). At still higher concentrations of capsazepine (>5 μM) and L-733006 (>0.5 μM), even higher concentrations of preconstricting agents could not produce a workable precontraction.
+
2006
2001
+
v
2+
+
Ca
Ca
2+
+
Ca
2004b
2006
1997
2006
) was investigated both in the absence or presence of 4-aminopyridine (1 mM). We also investigated the effect of the gap junction inhibitor 18-α-glycyrrhetinic acid (10 μM) on capsaicin-induced relaxations. Where indicated, the endothelium was removed with a human hair, and removal was confirmed by observing a relaxation of less than 10% of precontraction of U46619 after addition of substance P.
Further, in porcine distal coronary artery, we also studied the effect of repeated administration of capsaicin (50 μM, four times) to verify the reproducibility of the responses in view of possible depletion of endogenous peptide pools or other agents.

Measurements of cAMP
g
, and cAMP was measured in 300 μl supernatant using the ELISA kit according to the instructions of the manufacturer (R&D Systems Europe, Abingdom, UK).

Measurements of CGRP in organ bath fluid
Human distal coronary artery segments were subjected to a similar protocol as during the functional studies, while bath fluids were collected after construction of the concentration response curve. The bath fluids were collected from the segments treated with vehicle and capsaicin (100 μM), and Krebs solution was used as a control. Bath fluids were stored in tubes containing aprotinin (0.6 TIU/ml) and stored at −80°C. A competitive radioimmunoassay (Peninsula Lab INC., San Carlos, CA, USA) was used according to the instructions of the manufacturer to measure the CGRP concentrations in the bath fluid.

Data presentation and statistical analysis
+
n
50
E
max
E
max
50
B
t
α
(1/n)
2003
P
 ≤ 0.05.

Compounds
8–37
N
l
-NAME, charybdotoxin, ruthenium red, substance P, U46619 and Y-27632 were purchased from Sigma-Aldrich (Zwijndrecht, The Netherlands), and KCl was obtained from Merck (Darmstadt, Germany). Capsaicin was dissolved in 70% ethanol, and the dilution series was also prepared in ethanol 70%. Capsazepine was dissolved in methanol; olcegepant was dissolved in a small amount of 1 N HCl and then diluted with distilled water. The other compounds were dissolved in distilled water, and all compounds were stored in aliquots at −80°C.


Results
Functional studies
Human arteries
n
n
n
1
1
Fig. 1
Effect of capsaicin or its vehicle in the absence or presence of various pharmacological agents or interventions in precontracted human and porcine distal coronary arteries



Table 1
Effect of various antagonists/interventions on capsaicin-induced relaxations in human isolated artery segments

n
)
E
max
 (%)
E
max

50

50



Human distal coronary artery

 (Control) (32)
94 ± 1

5.27 ± 0.12


Olcegepant (1 μM) (10)
89 ± 4
8 ± 4
4.84 ± 0.09
0.33 ± 0.16

8–37
 (10 μM) (5)
96 ± 3
3 ± 4
4.79 ± 0.06
0.16 ± 0.08

Capsazepine (5 μM) (13)
91 ± 3
1 ± 2
5.10 ± 0.13
0.07 ± 0.16

Ruthenium red (0.1 mM) (9)

92 ± 3
5 ± 3
5.01 ± 0.13
0.21 ± 0.22

L-733060 (5 μM) (7)
94 ± 2
2 ± 2
6.03 ± 0.78
−0.54 ± 0.34

Denuded endothelium (5)
90 ± 6
9 ± 5
5.34 ± 0.48
−0.21 ± 0.58

l
-NAME (0.1 mM) (7)
94 ± 2
3 ± 2
5.23 ± 0.48
−0.24 ± 0.45

18-α-Glycyrrhetinic acid (10 μM) (3)
96 ± 2
0 ± 2
5.08 ± 0.28
−0.15 ± 0.38

Olcegepant (1 μM) + L-733060 (5 μM) (3)
90 ± 6
1 ± 3
6.04 ± 0.23
0.06 ± 0.21

 (Control) (10)

97 ± 1

5.91 ± 0.32


4-Aminopyridine (1 mM) (6)

95 ± 2
2 ± 3
5.64 ± 0.38
0.94 ± 0.46

Charybdotoxin (0.5 μM) + apamin (0.1 μM) (8)

97 ± 1
0 ± 1
5.80 ± 0.37
0.23 ± 0.37

Iberiotoxin (0.5 μM) + apamin (0.1 μM) (5)

96 ± 2
0 ± 2
5.94 ± 0.65
0.15 ± 0.38

Y-276323 (1 μM) (3)

99 ± 1
−1 ± 2
5.39 ± 0.21
−0.58 ± 0.14

Y-276323 (1 μM) + 4-Aminopyridine (1 mM) (3)

100 ± 0
−3 ± 4
5.12 ± 0.18
0.33 ± 0.28

Human proximal coronary artery

 (Control) (4)


34 ± 14
4.30 ± 0.14

Olcegepant (1 μM) (4)


36 ± 16
4.40 ± 0.17

Human meningeal artery

 (Control) (10)
91 ± 5 

5.04 ± 0.09


Olcegepant (1 μM) (10)
96 ± 1
−5 ± 4
5.03 ± 0.07
−0.07 ± 0.08

Capsazepine (5 μM) (4)
81 ± 9
8 ± 7
4.90 ± 0.31
0.11 ± 0.31

Ruthenium red (0.1 mM) (3)
74 ± 15
5 ± 14
5.13 ± 0.42
0.02 ± 0.62

L-733060 (5 μM) (4)
79 ± 12
8 ± 15
4.80 ± 0.31
−0.09 ± 0.31



E
max
50
50
50
 is the concentration of agonist required to produce half the maximal response. The arteries were precontracted with KCl (18–30 mM) except where KCl (45–90 mM; bold) or U46619 (ital).



8–37
1
1
1
l
1
+
2+
1
50
50
P
50
n
50
n
1
).

Porcine arteries
n
n
n
n
2
l
1
2
1
2
Table 2
Effect of various antagonists/interventions on capsaicin-induced relaxations in porcine isolated artery segments

n
)
E
max
 (%)
E
max

50

50



Porcine distal coronary artery

 (Control) (56)
96 ± 1

5.27 ± 0.09


Olcegepant (1 μM) (10)
92 ± 2
3 ± 2
5.26 ± 0.11
−0.02 ± 0.11

8–37
 (10 μM) (5)
97 ± 3
−2 ± 5
4.78 ± 0.06
0.00 ± 0.03

Capsazepine (5 μM) (7) 
99 ± 1
−3 ± 2
5.15 ± 0.26
0.26 ± 0.16

Ruthenium red (0.1 mm) (12)

88 ± 3
7 ± 4
4.89 ± 0.09
0.47 ± 0.23

L-733060 (5 μM) (7)
88 ± 3
4 ± 4
4.89 ± 0.09
−0.04 ± 0.15

Denuded endothelium (9)
91 ± 4
2 ± 2
5.62 ± 0.49
0.21 ± 0.16

l
-NAME (0.1 mM) (6)
90 ± 8
8 ± 8
4.84 ± 0.15
0.28 ± 0.31

 (Control) (15)

99 ± 0

5.08 ± 0.15


18-α-Glycyrrhetinic acid (10 μM) (3)

99 ± 1
0 ± 1
5.73 ± 0.75
−0.59 ± 0.53

4-Aminopyridine (1 mM) (7)

96 ± 2
3 ± 2
4.84 ± 0.15
−0.46 ± 0.35

Charybdotoxin (0.5 μM) + apamin (0.1 μM) (11)

99 ± 1
0 ± 1
5.27 ± 0.15
−0.04 ± 0.20

Y-276323 (1 μM) (9)

96 ± 2
3 ± 2
5.17 ± 0.19
0.04 ± 0.21

Y-276323 (1 μM) + 4-Aminopyridine (1 mM) (8)

96 ± 3
4 ± 3
5.22 ± 0.20
0.00 ± 0.11

Porcine proximal coronary artery

 (Control) (4)
100 ± 0

5.33 ± 0.42


Olcegepant (1 μM) (4)
90 ± 6

5.79 ± 0.16


Porcine basilar artery

 (Control) (3)
97 ± 1

4.70 ± 0.05


Olcegepant (1 μM) (3)
100 ± 0

4.97 ± 0.24


Capsazepine (5 μM) (3) 
100 ± 0

4.80 ± 0.01


Porcine meningeal artery

 (Control) (3)
99 ± 1

4.82 ± 0.02


Olcegepant 1 μM (3)
99 ± 1

4.88 ± 0.04




E
max
50
50
50
 is the concentration of agonist required to produce half the maximal response. The arteries were precontracted with KCl (18–30 mM) except where KCl (45–90 mM; bold) or U46619 (ital).


Fig. 2
Effect of four consecutive challenges to capsaicin (50 μM) in porcine distal coronary arteries precontracted with KCl (30 mM)




E
max
50
n
E
max
50
n
 = 3) arteries as compared to porcine distal coronary arteries. In both these arteries, responses to capsaicin were not affected by olcegepant (1 μM).

Measurements of cAMP
3
Fig. 3
n
n
P
 < 0.05) from KCl (30 mM)-treated segments





Measurements of CGRP levels in organ bath fluid
4
Fig. 4
P
 < 0.05) from Krebs buffer







Discussion
In the present study, we investigated the role of CGRP in capsaicin-induced relaxations in human and porcine isolated arteries. In all arteries investigated, there does not seem to be any relevant role of CGRP in the relaxant responses to capsaicin. Further, the effects of capsaicin appear to be mediated by non-specific mechanisms.
1991a
2006
8–37
1989
1991b
8–37
1991b
), although we could not block these responses even at 10-μM concentration.
2006c
1991a
1991a
2002
2004
1
50
2006c
1991a
1997
), did not block responses to capsaicin in our study.
+
2001
1997
+
+
2001
2006
Ca
Ca
1997
Ca
2006
2001
1990
+
l
S
2004b
2001
1997
2001
) than those employed by others.
2+
+
 channels. The relaxations to capsaicin are mediated by a cAMP independent pathway. The major component of capsaicin-induced relaxations, therefore, appears to be mediated by non-specific actions of capsaicin, rather than from the release of neuropeptides like CGRP.


References
Akerman
S

Kaube
H

Goadsby
PJ


Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation
Br J Pharmacol
2003
140
718
724
10.1038/sj.bjp.0705486

14534154


Arulmani
U

Heiligers
JPC

Garrelds
IM

Sánchez-López
A

Willems
EW

Villalón
CM

Saxena
PR


Effects of sumatriptan on capsaicin-induced carotid haemodynamic changes and CGRP release in anaesthetized pigs
Cephalalgia
2004
24
717
727
10.1111/j.1468-2982.2004.00743.x

15315527


Arulmani
U

MaassenVanDenBrink
A

Villalón
CM

Saxena
PR


Calcitonin gene-related peptide and its role in migraine pathophysiology
Eur J Pharmacol
2004
500
315
330
10.1016/j.ejphar.2004.07.035

15464043


Arulmani
U

Gupta
S

MaassenVanDenBrink
A

Centurión
D

Villalón
CM

Saxena
PR


Experimental migraine models and their relevance in migraine therapy
Cephalalgia
2006
26
642
659
10.1111/j.1468-2982.2005.01082.x

16686903


Batenburg
WW

Garrelds
IM

Bernasconi
CC

Juillerat-Jeanneret
L

Kats
JP

Saxena
PR

Danser
AHJ


Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries
Circulation
2004
109
2296
2301
10.1161/01.CIR.0000128696.12245.57

15117835


Batenburg
WW

Popp
R

Fleming
I

Vries
R

Garrelds
IM

Saxena
PR

Danser
AHJ


S
-nitrosothiols as EDHF
Br J Pharmacol
2004
142
125
135
10.1038/sj.bjp.0705747

15066907


Caterina
MJ

Schumacher
MA

Tominaga
M

Rosen
TA

Levine
JD

Julius
D


The capsaicin receptor: a heat-activated ion channel in the pain pathway
Nature
1997
389
816
824
10.1038/39807

9349813


Chai
W

Mehrotra
S

Danser
AHJ

Schoemaker
RG


The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts
Eur J Pharmacology
2006
531
246
253
10.1016/j.ejphar.2005.12.039

Chai W, Mehrotra S, Danser AHJ, Schoemaker RG (2006) The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts. Eur J Pharmacology 531:246–253 

Delepine
L

Aubineau
P


Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion
Exp Neurol
1997
147
389
400
10.1006/exnr.1997.6614

9344563


Dong
YL

Green
KE

Vegiragu
S

Hankins
GD

Martin
E

Chauhan
M

Thota
C

Yallampalli
C


Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies
J Clin Endocrinol Metab
2005
90
2336
2343
10.1210/jc.2004-1481

15623815


Doods
H

Hallermayer
G

Wu
D

Entzeroth
M

Rudolf
K

Engel
W

Eberlein
W


Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
Br J Pharmacol
2000
129
420
423
10.1038/sj.bjp.0703110

10711339


Edvinsson
L

Ekman
R

Jansen
I

McCulloch
J

Uddman
R


Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects
J Cereb Blood Flow Metab
1987
7
720
728

3500957


Edvinsson
L

Alm
R

Shaw
D

Rutledge
RZ

Koblan
KS

Longmore
J

Kane
SA


Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells
Eur J Pharmacol
2002
434
49
53
10.1016/S0014-2999(01)01532-1

11755165


Franco-Cereceda
A


Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone
Acta Physiol Scand Suppl
1988
569
1
63

3266056


Franco-Cereceda
A


Calcitonin gene-related peptide and human epicardial coronary arteries: presence, release and vasodilator effects
Br J Pharmacol
1991
102
506
510

1707713


Franco-Cereceda
A


Resiniferatoxin-, capsaicin- and CGRP-evoked porcine coronary vasodilatation is independent of EDRF mechanisms but antagonized by CGRP(8–37)
Acta Physiol Scand
1991
143
331
337

1722940


Franco-Cereceda
A

Rudehill
A


Capsaicin-induced vasodilatation of human coronary arteries in vitro is mediated by calcitonin gene-related peptide rather than substance P or neurokinin A
Acta Physiol Scand
1989
136
575
580

2476911


Franco-Cereceda
A

Rudehill
A

Lundberg
JM


Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig
Eur J Pharmacol
1987
142
235
243
10.1016/0014-2999(87)90112-9

2446887


Franco-Cereceda
A

Lundberg
JM

Saria
A

Schreibmayer
W

Tritthart
HA


Calcitonin gene-related peptide: release by capsaicin and prolongation of the action potential in the guinea-pig heart
Acta Physiol Scand
1988
132
181
190

2852435


Fujimoto
S

Mori
M

Tsushima
H

Kunimatsu
M


Capsaicin-induced, capsazepine-insensitive relaxation of the guinea-pig ileum
Eur J Pharmacol
2006
530
144
151
10.1016/j.ejphar.2005.11.011

16360146


Gazzieri
D

Trevisani
M

Tarantini
F

Bechi
P

Masotti
G

Gensini
GF

Castellani
S

Marchionni
N

Geppetti
P

Harrison
S


Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide
Cardiovasc Res
2006
70
589
599
10.1016/j.cardiores.2006.02.027

16579978


Goadsby
PJ

Lipton
RB

Ferrari
MD


Migraine—current understanding and treatment
N Engl J Med
2002
346
257
270
10.1056/NEJMra010917

11807151


Gunthorpe MJ, Benham CD, Randall A, Davis JB (2002) The diversity in the vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci 23:183–191

Gupta
S

Akerman
S

Maagdenberg
AMJM

Saxena
PR

Goadsby
PJ

MaassenVanDenBrink
A


Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine
Cephalalgia
2006
26
11
1294
1303
10.1111/j.1468-2982.2006.01219.x

17059436


Gupta
S

Mehrotra
S

Avezaat
CJJ

Villalón
CM

Saxena
PR

MaassenVanDenBrink
A


Characterisation of CGRP receptors in the human isolated middle meningeal artery
Life Sci
2006
79
265
271
10.1016/j.lfs.2006.01.003

16458930


Gupta
S

Mehrotra
S

Villalón
CM

Garrelds
IM

Vries
R

Kats
JP

Sharma
HS

Saxena
PR

MaassenVanDenBrink
A


Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity
Eur J Pharmacol
2006
530
107
116
10.1016/j.ejphar.2005.11.020

16375887


Maggi
CA

Patacchini
R

Perretti
F

Tramontana
M

Manzini
S

Geppetti
P

Santicioli
P


Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery
Naunyn Schmiedebergs Arch Pharmacol
1990
342
78
84
10.1007/BF00178976

1698264


Mitchell
RW

Ndukwu
IM

Herrnreiter
A

Uzendoski
K

Gitter
B

Solway
J

Leff
AR


Differential tachykinin receptor subtype activation in capsaicin and KCl contractions of guinea pig trachealis
Am J Physiol
1995
269
L837
L842

8572245


Motulsky HJ (2003) Prism 4 statistics guide—statistical analyses for laboratory and clinical researchers. GraphPad Software Inc., San Diego, CA. www.graphpad.com

Nyborg
NC

Baandrup
U

Mikkelsen
EO

Mulvany
MJ


Active, passive and myogenic characteristics of isolated rat intramural coronary resistance arteries
Pflügers Arch
1987
410
664
670
10.1007/BF00581329

3449802


Olesen
J

Diener
HC

Husstedt
IW

Goadsby
PJ

Hall
D

Meier
U

Pollentier
S

Lesko
LM


Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
N Engl J Med
2004
350
1104
1110
10.1056/NEJMoa030505

15014183


Sams-Nielsen
A

Orskov
C

Jansen-Olesen
I


Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals
Br J Pharmacol
2001
132
1145
1153
10.1038/sj.bjp.0703910

11226146


Seabrook
GR

Shepheard
SL

Williamson
DJ

Tyrer
P

Rigby
M

Cascieri
MA

Harrison
T

Hargreaves
RJ

Hill
RG


2+
i
 mobilisation, cardiovascular and dural extravasation assays
Eur J Pharmacol
1996
317
129
135
10.1016/S0014-2999(96)00706-6

8982729


Szallasi
A


Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations
Naunyn Schmiedebergs Arch Pharmacol
2006
373
273
286
10.1007/s00210-006-0072-3

16773387


Tang
YH

Lu
R

Li
YJ

Deng
HW

Liu
GZ


Protection by capsaicin against attenuated endothelium-dependent vasorelaxation due to lysophosphatidylcholine
Naunyn Schmiedebergs Arch Pharmacol
1997
356
364
367
10.1007/PL00005063

9303574


Tang
ZL

Dai
W

Li
YJ

Deng
HW


Involvement of capsaicin-sensitive sensory nerves in early and delayed cardioprotection induced by a brief ischaemia of the small intestine
Naunyn Schmiedebergs Arch Pharmacol
1999
359
243
247
10.1007/PL00005348

10208312


Trevisani
M

Gazzieri
D

Benvenuti
F

Campi
B

Dinh
QT

Groneberg
DA

Rigoni
M

Emonds-Alt
X

Creminon
C

Fischer
A

Geppetti
P

Harrison
S


Ethanol causes inflammation in the airways by a neurogenic and TRPV1-dependent mechanism
J Pharmacol Exp Ther
2004
309
1167
1173
10.1124/jpet.103.064162

14762103


Trevisani
M

Smart
D

Gunthorpe
MJ

Tognetto
M

Barbieri
M

Campi
B

Amadesi
S

Gray
J

Jerman
JC

Brough
SJ

Owen
D

Smith
GD

Randall
AD

Harrison
S

Bianchi
A

Davis
JB

Geppetti
P


Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1
Nat Neurosci
2002
5
546
551
10.1038/nn852

11992116


Yeon
D

Kwon
S

Lee
Y

Leem
J

Nam
T

Ahn
D


Capsaicin-induced relaxation in rabbit coronary artery
J Vet Med Sci
2001
63
499
503
10.1292/jvms.63.499

11411493


Zhou
ZH

Peng
J

Ye
F

Li
NS

Deng
HW

Li
YJ


Delayed cardioprotection induced by nitroglycerin is mediated by alpha-calcitonin gene-related peptide
Naunyn Schmiedebergs Arch Pharmacol
2002
365
253
259
10.1007/s00210-002-0537-y

11919648


Zhu
FX

Zhang
XY

Olszewski
MA

Robinson
NE


Mechanism of capsaicin-induced relaxation in equine tracheal smooth muscle
Am J Physiol
1997
273
L997
L1001

9374726





